ライフサイエンスコーパス: fungemia

1 as frequent in patients with Aspergillus spp fungemia.

2 FFSC, Neocosmospora spp, and L. prolificans fungemia.

3 ons were frequent in cases of L. prolificans fungemia.

4 d outcomes associated with C. guilliermondii fungemia.

5 ltimately established a sustained, low-level fungemia.

6 aluate patients for ocular manifestations of fungemia.

7 serum or CSF cryptococcal antigen titers and fungemia.

8 sured in serum from patients with persistent fungemia.

9 ations in 1,436 patients with bacteremia and fungemia.

10 d in the urine of a patient with C. albicans fungemia.

11 the intensive care unit when they developed fungemia.

12 diagnosed with EE in the setting of Candida fungemia.

13 ty of the ESP blood culture system to detect fungemia.

14 the incidence of Gram-positive bacteremia or fungemia.

15 atients who were at increased risk of having fungemia.

16 cluding 121 episodes of bacteremia and 12 of fungemia.

17 adult patients with suspected bacteremia or fungemia.

18 btaining blood for culture for bacteremia or fungemia.

19 culture system for detecting bacteremia and fungemia.

20 sis, occurring in 0.04-0.5% of bacteremia or fungemia.

21 ative bacteremia, and from 0.6% to 26.1% for fungemia.

22 adult patients with suspected bacteremia or fungemia.

23 osts in patients with documented C. glabrata fungemias.

24 cases of bacteremia (7.5%) and 370 cases of fungemia (0.7%).

25 mia (1.6%), gram-positive bacteremia (1.6%), fungemia (1.6%), and documented or suspected aspergillos

26 Of 248 separate episodes of bacteremia or fungemia, 146 were detected by both systems, 56 were det

27 = .16), incidence of secondary bacteremia or fungemia (15% for the ganciclovir group vs 15% for the p

28 croM/mg/dl 3 or more days after the onset of fungemia (18/27 versus 4/24 patients, respectively; P <

29 Of the 36 clinically important episodes of fungemia, 22 were detected by both systems (13 C. albica

30 infection (82.7% vs. 20%, P = 0.00001), and fungemia (29% vs. 8%, P = 0.046) were more likely to rec

31 e mycobacteremia (57/182 vs. 0/64, P<.0001), fungemia (38/182 vs. 2/64, P<.001), or polymicrobial BSI

32 en of the 21 patients died within 60 days of fungemia, although mortality was directly or partially a

33 thalmitis was 0.05%-0.4% among patients with fungemia and 0.04% among patients with bacteremia.

34 We present a case of S. cerevisiae fungemia and aortic graft infection in an immunocompeten

35 ul both for the initial diagnosis of Candida fungemia and for prognostic purposes for unselected pati

36 ation between the incidence of bacteremia or fungemia and intravenous lipid (P = 0.95).

37 e major infection (pneumonia, bacteremia, or fungemia) and death; if the true probability of either e

38 s, 100 hospitalized controls without Candida fungemia, and 83 patients from a study of all Candida fu

39 , severe lung pathology, elevated serum IgE, fungemia, and cryptococcal dissemination in the central

40 three predictors (serum antigen titer >1:64, fungemia, and late-onset disease) independently identifi

41 Catheter-associated W. dermatitidis fungemia appears to be distinct from previously describe

42 with fungemia, overall data on mold-related fungemia are limited, hampering early management.

43 cT/ALERT aerobic medium for the detection of fungemia as well as bacteremia.

44 ed at reducing hospital-onset bacteremia and fungemia associated with all types of vascular access de

45 id organs from donors with bacteremia and/or fungemia at the time of organ recovery.

46 Only 18 of the 151 clinical episodes of fungemia attributable to yeast were not detected by auto

47 ounts for a significant number of nosocomial fungemias, but in fact, no effective and verified geneti

48 Bacteremia and fungemia can cause life-threatening illness with high mo

49 ida glabrata than in patients with cancer or fungemia caused by a DA producer, C. albicans, C. tropic

50 ere less frequent in patients with cancer or fungemia caused by the DA nonproducer Candida glabrata t

51 method combining septicemia, bacteremia, and fungemia codes (P < .001 for linear trend) to a 706% inc

52 ard-dose lipid group developed bacteremia or fungemia compared with 54 in the low-dose lipid group.

53 increased yields in detecting bacteremia and fungemia compared with standard BacT/Alert (STD) bottles

54 and severity of illness, correlated with the fungemia due to a non-albicans species.

55 We report an outbreak investigation of fungemia due to Penicillium species after prolonged floo

56 ted the financial impact of the treatment of fungemias due to Candida glabrata from a hospital perspe

57 ion compared the incidence of bacteremia and fungemia during the first month after the transplant.

58 te lymphoblastic leukemia and Candida krusei fungemia failed therapy with fluconazole and amphoterici

59 BDG determinations throughout the episode of fungemia (Fungitell Assay; positive cut-off >=80pg/mL).

60 The high-risk fungemia group had 252 fungemic cultures compared with o

61 ic types of infections, 53% of patients with fungemia had complete responses, and 52% of patients wit

62 The gradient boosting machine model for fungemia had high discrimination (area under the receive

63 ty-two (9.2%) of 238 consulted patients with fungemia had ocular involvement.

64 Hospital-onset bacteremia and fungemia (HOB) are common and potentially preventable co

65 ings to reduce hospital-onset bacteremia and fungemia (HOB) events.

66 tients have known or suspected bacteremia or fungemia; however, culture yield is reported to be low (

67 n days, incidence of secondary bacteremia or fungemia, ICU length of stay, mortality, and ventilator-

68 t fungal isolates involved in 36 episodes of fungemia in 34 patients.

69 high serum cryptococcal antigen titer and/or fungemia in 95% of evaluable cases.

70 ssociated Wangiella (Exophiala) dermatitidis fungemia in a human immunodeficiency virus-infected chil

71 adequate for the detection of bacteremia and fungemia in adults, a recent study found that two blood

72 ory cytokines are associated with persistent fungemia in candidemia patients.

73 tric blood culture tube for the detection of fungemia in children was assessed by a 10-year retrospec

74 ul clinical information for the diagnosis of fungemia in children, with the exception of M. furfur an

75 Alert 3D (BTA3D) for detection of bacteremia/fungemia in four bottle types, SA and FA Plus (aerobic)

76 t Systems, Sparks, Md.) for the detection of fungemia in hospitalized pediatric patients.

77 mortality associated with C. guilliermondii fungemia in immunocompromised patients, emphasizing the

78 or partially attributed to C. guilliermondii fungemia in only four cases (19.0%).

79 and 83 patients from a study of all Candida fungemias in Connecticut between October 1998 and Septem

80 Fungemia including polymicrobial infection was due to: C

81 ablishment and maintenance of this sustained fungemia is an important stage of disease progression th

82 Fungemia, mostly due to Candida spp., was rare in cancer

83 fungal blood cultures (n = 215) or suspected fungemia (n = 12).

84 Presentations included fungemia (n = 2), multifocal lymphadenopathy (n = 2), an

85 ion and may result in antibiotic resistance, fungemia, necrotizing enterocolitis (NEC), and mortality

86 Persistent fungemia occurred in 13% of cases.

87 Fungemia occurred in 333 (0.23%; 95% confidence interval

88 s at one hospital developed Candida albicans fungemia or endophthalmitis.

89 5.24), while antifungal prophylaxis prior to fungemia (OR 0.20, 95% CI, .06-.62) and remission of und

90 ans (odds ratio [OR], 33.3), Aspergillus spp fungemia (OR, 14.2), and corticosteroid exposure (OR, 7.

91 cryptococcosis who have late-onset disease, fungemia, or serum cryptococcal antigen titer more than

92 urs of life) infection including bacteremia, fungemia, or surgical peritonitis.

93 ntosporiosis are known to be associated with fungemia, overall data on mold-related fungemia are limi

94 sepsis (quick SOFA>=2, P=0.03 and P<0.001), fungemia (P<0.001 and P=0.01) and intensive care admissi

95 P=.023), renal failure at baseline (P=.028), fungemia (P=.006), and disseminated infection (P=.035) a

96 The average age of fungemia patients with EE was 54.6 years and of those wi

97 s drawn for 30 (36%), 22 (27%), and 11 (13%) fungemia patients, respectively.

98 Our data suggest that sustained fungemia resulted from a pattern of repeated escape from

99 for Research and Treatment of Cancer (EORTC) fungemia survey, and there are few recent large epidemio

100 , Md.) allowed detection of more episodes of fungemia than did a resin-containing medium with equal v

101 fford more rapid detection of bacteremia and fungemia than is possible with non-instrument-based manu

102 icroorganisms and episodes of bacteremia and fungemia than Standard Anaerobic/F bottles as companion

103 For fungemia, the MFL bottle was as sensitive as the SC-B bo

104 jority (76.2%) of cases of C. guilliermondii fungemia treated at our tertiary care center were hospit

105 ents at low and high-risk for bacteremia and fungemia using routinely collected electronic health rec

106 For the subgroup of subjects whose fungemia was diagnosed while they were in the intensive

107 blinded determination of true bacteremia or fungemia was made by two infectious disease specialists.

108 isms from adult patients with bacteremia and fungemia, we compared Plus Anaerobic/F bottles with Stan

109 isms from adult patients with bacteremia and fungemia, we compared the BacT/ALERT FN (FN) anaerobic b

110 ce, clinical characteristics, and outcome of fungemia were analyzed.

111 All patients with Trichoderma spp fungemia were exposed to corticosteroids.Day 90 mortalit

112 A total of 54 episodes of fungemia were identified, with 40 detected by both media

113 yptococcal antigen titer more than 1:64, and fungemia were independently associated with an increased

114 Disseminated disease and fungemia were present in 76.8% (86/112) and 90-day morta

115 is the first reported case of S. cerevisiae fungemia where the identity of the pathogen was confirme

116 ay a valuable role in limiting the sustained fungemia, which can lead to meningoencephalitis.

117 od volumes required to detect bacteremia and fungemia with low concentrations of an organism.

118 Although shock developed soon after fungemia with the C. albicans clinical isolate, TNF-alph